CRP and irritable bowel syndrome: From a molecular point of view, IBD and IBS diagnoses are mainly based on the specific methodology described below, associating clinical symptom observations with family history and the quantification of fecal calprotectin or lactoferrin and C-reactive protein, an overall inflammation biomarker [12].